Joan Montaner Selected Research

Joan Montaner Research Topics

Disease

221	Stroke (Strokes) 05/2024 - 06/2002
122	Ischemic Stroke 05/2024 - 04/2003
37	Brain Ischemia (Cerebral Ischemia) 11/2023 - 02/2003
26	Cerebral Hemorrhage 01/2023 - 07/2003
23	Inflammation (Inflammations) 04/2024 - 07/2006
22	Infarction (Infarctions) 11/2022 - 06/2002
19	Ischemia 11/2023 - 02/2003
17	Brain Injuries (Brain Injury) 11/2023 - 07/2005
14	Atrial Fibrillation 12/2022 - 08/2008
13	Hemorrhagic Stroke 06/2023 - 06/2006
12	Pneumonia (Pneumonitis) 01/2024 - 08/2015
12	Infections 01/2024 - 01/2011
10	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2023 - 08/2010
9	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 07/2022 - 07/2005
9	Embolic Stroke 01/2022 - 02/2004
9	Hemorrhage 01/2020 - 02/2003
8	Transient Ischemic Attack 01/2024 - 10/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 02/2023 - 04/2007
8	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023 - 09/2004
8	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 01/2015
8	Hypertension (High Blood Pressure) 01/2019 - 02/2014
6	Hypoxia (Hypoxemia) 02/2024 - 01/2013
6	Atherosclerosis 01/2024 - 12/2007
6	Myocardial Infarction 12/2022 - 02/2010
6	Brain Infarction 01/2022 - 10/2013
6	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2016 - 02/2012
5	Thrombosis (Thrombus) 01/2024 - 02/2008
5	Wounds and Injuries (Trauma) 11/2023 - 08/2008
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2017 - 11/2006
4	Epilepsy (Aura) 04/2024 - 05/2020
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2024 - 09/2011
4	Seizures (Absence Seizure) 11/2023 - 01/2020
4	Hypothermia 11/2023 - 02/2014
4	Diabetes Mellitus 01/2018 - 05/2003
4	Edema (Dropsy) 01/2014 - 11/2005
3	Brain Edema (Cerebral Edema) 01/2023 - 03/2007
3	Amyloidosis 01/2023 - 11/2017
3	Cognitive Dysfunction 12/2022 - 01/2020
3	Hematoma 07/2021 - 06/2013
3	Brain Concussion (Cerebral Concussion) 01/2018 - 01/2017
3	Cerebral Small Vessel Diseases 10/2017 - 12/2014

Drug/Important Bio-Agent (IBA)

88	Biomarkers (Surrogate Marker)IBA 05/2024 - 11/2006
53	Tissue Plasminogen Activator (Alteplase)FDA Link 06/2023 - 06/2002
33	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2003
26	Matrix Metalloproteinases (MMPs)IBA 07/2021 - 02/2003
15	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2024 - 03/2005
12	C-Reactive ProteinIBA 01/2024 - 10/2003
11	Matrix Metalloproteinase 9 (Gelatinase B)IBA 10/2020 - 02/2003
10	Neuroprotective AgentsIBA 01/2023 - 07/2014
8	Brain Natriuretic Peptide (Natrecor)FDA Link 05/2024 - 12/2013
8	Oxygen (Dioxygen)IBA 02/2024 - 04/2010
8	Glucose (Dextrose)FDA LinkGeneric 02/2024 - 05/2003
8	Anti-Bacterial Agents (Antibiotics)IBA 01/2024 - 12/2012
8	Amyloid (Amyloid Fibrils)IBA 01/2023 - 07/2009
7	pro-brain natriuretic peptide (1-76)IBA 05/2024 - 12/2013
7	Apolipoproteins E (ApoE)IBA 01/2023 - 12/2010
7	EnzymesIBA 03/2021 - 04/2003
7	Metalloproteases (Metalloproteinases)IBA 08/2019 - 07/2005
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2024 - 01/2009
6	LipidsIBA 01/2021 - 03/2005
6	fibrin fragment D (D-dimer)IBA 01/2021 - 07/2006
6	Simvastatin (Zocor)FDA LinkGeneric 02/2018 - 07/2012
6	CytokinesIBA 10/2016 - 11/2009
5	Fibrinogen (Factor I)FDA Link 04/2024 - 05/2006
5	Interleukin-6 (Interleukin 6)IBA 01/2024 - 09/2014
5	EndostatinsIBA 02/2021 - 01/2005
5	Natriuretic PeptidesIBA 01/2021 - 12/2013
5	ChemokinesIBA 01/2020 - 01/2009
5	erucylphosphocholineIBA 01/2018 - 12/2010
4	omega-Chloroacetophenone (Mace)IBA 04/2024 - 12/2022
4	ProteomeIBA 01/2023 - 11/2010
4	salicylhydroxamic acid (SHAM)IBA 07/2022 - 01/2014
4	ImmunosorbentsIBA 03/2021 - 04/2003
4	Clopidogrel (Plavix)FDA Link 01/2020 - 01/2015
4	CholesterolIBA 02/2018 - 01/2008
4	Thrombin FDA Link 08/2017 - 04/2003
4	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 12/2014 - 09/2011
4	Plasminogen Activator Inhibitor 1IBA 05/2014 - 06/2004
3	ProcalcitoninIBA 05/2024 - 08/2015
3	Blood Glucose (Blood Sugar)IBA 11/2023 - 04/2006
3	Lipoproteins (Lipoprotein)IBA 01/2023 - 11/2017
3	AnticoagulantsIBA 01/2022 - 01/2009
3	Amyloid beta-PeptidesIBA 01/2021 - 08/2010
3	Glial Fibrillary Acidic ProteinIBA 10/2020 - 01/2016
3	Therapeutic UsesIBA 03/2020 - 07/2010
3	Natalizumab (Tysabri)FDA Link 01/2020 - 01/2016
3	ApolipoproteinsIBA 01/2019 - 01/2016
3	human AOC3 proteinIBA 02/2018 - 07/2010
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2016 - 01/2014

Therapy/Procedure

67	Therapeutics 04/2024 - 01/2003
14	Secondary Prevention 04/2024 - 03/2005
14	Thrombolytic Therapy 06/2023 - 07/2005
8	Thrombectomy 12/2023 - 01/2016
8	Transplantation 01/2023 - 08/2012
4	Time-to-Treatment 09/2023 - 09/2004
4	Lasers (Laser) 01/2018 - 06/2009
3	Stents 01/2024 - 01/2016
3	Induced Hypothermia 11/2023 - 07/2014
3	Mediterranean Diet 01/2022 - 05/2019
3	Carotid Endarterectomy 03/2020 - 07/2006